ARTICLE | Company News
CuraGen creates spin-off
June 6, 2000 7:00 AM UTC
CRGN launched a majority-owned subsidiary, 454 Corp., to develop technologies to perform massively parallel genomic analysis, leaving the parent to focus on its product development pipeline. 454 Corp....